ESSA Pharma earnings beat by $0.10, revenue was inline with estimates

  • Investing.com
ESSA Pharma earnings beat by $0.10, revenue was inline with estimates

Investing.com - ESSA Pharma (NASDAQ: EPIX) reported first quarter EPS of $-0.15, $0.10 better than the analyst estimate of $-0.25. Revenue for the quarter came in at $0.00 versus the consensus estimate of $0.00.

ESSA Pharma's stock price closed at $2.90. It is down -11.85% in the last 3 months and down -72.86% in the last 12 months.

ESSA Pharma saw 1 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See ESSA Pharma's stock price’s past reactions to earnings here.

According to InvestingPro, ESSA Pharma's Financial Health score is "performance".

Check out ESSA Pharma's recent earnings performance , and ESSA Pharma's financials here.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles